Finance

Beta
Ask
Lists
ABEO:NASDAQ
Abeona Therapeutics Inc
$5.72
-0.52%
(-0.030) 1D
$5.73
+0.17% (+0.010)
Pre-market
Closed: Jun 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABEO...
Open
$5.68
High
$5.87
Low
$5.67
Mkt. cap
326.01M
Avg. vol.
1.08M
Volume
1.13K
P/E ratio
6.61
52-wk high
$7.54
52-wk low
$4.00
EPS
$0.87
Beta
1.35
Shares outstanding
57.00M
No. of employees
226
Open
$5.68
High
$5.87
Low
$5.67
Mkt. cap
326.01M
Avg. vol.
1.08M
Volume
1.13K
P/E ratio
6.61
52-wk high
$7.54
52-wk low
$4.00
EPS
$0.87
Beta
1.35
Shares outstanding
57.00M
No. of employees
226
News stories
From sources across the web
About Abeona Therapeutics Inc
CEO-
Employees226
Founded1974
HeadquartersCleveland, Ohio, United States
SectorBiotechnology
Websiteabeonatherapeutics.com
Analyst Ratings
Based on 4 analysts giving stock ratings to ABEO in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ABEO in the last 3 months.
Highest
Current $5.72
$22.00 (+284.62%)
Average
$19.75 (+245.28%)
Lowest
$17.00 (+197.20%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+249.7%
05/28/2026
Unknown Analyst
Jefferies
Buy
Maintained
$17.00
+197.2%
05/14/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$22.00
+284.6%
05/14/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$20.00
+249.7%
05/13/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$17.00
+197.2%
03/18/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$28.00
+389.5%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
400.00K
-
5.42M
8.72M
Cost of goods sold
6.04M
4.70M
9.55M
12.25M
Cost of revenue
6.04M
4.70M
9.55M
12.25M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.15M
19.31M
18.78M
19.50M
Operating expense
17.15M
19.31M
18.78M
19.50M
Total operating expenses
23.19M
24.02M
28.33M
31.75M
Operating income
-22.79M
-24.02M
-22.91M
-23.03M
Other non operating income
-5.30M
2.89M
1.57M
5.44M
EBT including unusual items
124.34M
-20.36M
-20.68M
-17.07M
EBT excluding unusual items
-28.02M
-20.36M
-20.68M
-17.07M
Income tax expense
15.51M
-15.20M
-215.00K
2.00K
Effective tax rate
12.47%
74.65%
1.04%
-0.01%
Other operating expenses
-
-
-
-
Net income
108.83M
-5.16M
-20.46M
-17.08M
Net profit margin
27,208.25%
-
-377.49%
-195.81%
Earnings per share
-0.47
-0.11
-0.37
-0.30
Interest and investment income
1.03M
1.67M
1.55M
1.35M
Interest expense
-957.00K
-901.00K
-884.00K
-830.00K
Net interest expenses
70.00K
771.00K
663.00K
524.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.25M
-23.41M
-22.05M
-22.34M
Gain or loss from assets sale
-152.37M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer